SCHEMBL4075885

SCHEMBL4075885

COc1cnc(-c2[nH]ccc2C)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.73
CYP2C19 P33261 6/20 0.66
CYP2D6 P10635 5/20 0.66
CYP3A4 P08684 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP2C8 P10632 1/20 0.66
CYP2B6 P20813 1/20 0.66
KCNH2 Q12809 1/20 0.66
ALDH1A1 P00352 2/20 0.40
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.39
KIT P10721 1/20 0.38
BTK Q06187 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426124 0.88 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763051 0.88 CYP2C9 (0.78) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763629 0.87 CYP2C9 (0.74) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763243 0.86 CYP2C9 (0.71) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL17861491 0.86 CYP2C9 (0.82) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL6422622 0.86 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763634 0.86 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763324 0.86 CYP2C9 (0.75) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763492 0.85 CYP2C9 (0.72) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL4071994 0.85 CYP2C9 (0.72) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363705-A4 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2009-08-12 EP disclosed
EP-1363705-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-11-26 EP disclosed
WO-2002062423-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-15 WO disclosed